References
- Ādamsone, I., Keišs, J., Konrāde, I., Lejniece, S., Lejnieks, A., Platkājis, A., Rozentāle, B., Sondore, V., Tolmane, I., Tolmanis, I. (2012). Klīniskā medicīna. Otrā grāmata [Clinical Medicine. Book Two]. Zvaigzne, Rīga, 213.–225. lpp. (in Latvian).
- AlBuhairan, F., Nasim, M., Al Otaibi, A., Shaheen, N. A., Al Jaser, S., Al Alwan, I. (2016). Health related quality of life and family impact of type 1 diabetes among adolescents in Saudi Arabia. Diabetes Res. Clin. Pract., 114, 173–179. DOI: 10.1016/j.diabres.2016.01.001. PMID: 26830857. https://pubmed.ncbi.nlm.nih.gov/26830857/.
- Anaya, J. M. (2014). The diagnosis and clinical significance of polyauto-immunity. Autoimmun. Rev., 13 (4/5), 423–426. https://linkinghub.elsevier.com/retrieve/pii/S1568-9972(14)00061-5 (accessed 10.03.2021).
- Babiker, A., Aqeel, B. A., Marie, S., Omer, H., Bahabri, A., Shaikh, A. A., Zahrani, N., Badri, M., Dubayee, M. A., Alwan, I. A. (2021). Quality of life and glycemic control in saudi children with type 1 diabetes at different developmental age groups. Clin. Med. Insights Endocrinol. Diabetes, 14, 1179551421990678. https://pubmed.ncbi.nlm.nih.gov/33628072/.
- Delli, A. J., Lernmark, A. (2016). Type 1 (insulin-dependent) Diabetes Mellitus: Etiology, pathogenesis, prediction, and prevention. In: Endocrinology. Elsevier, Ch. 39, pp. 672-690.e5. https://clinicalgate.com/type-1-insulin-dependent-diabetes-mellitus-etiologypathogenesis-prediction-and-prevention/ (accessed 20.02.2021).
- Dzīvīte-Krišāne, I., Kirillova, I., Lauga-Tuņina, U. (2018). Endokrīno slimību agrīna diagnostika bērniem – cukura diabēts. Algoritms [Early diagnosis of endocrine diseases in children - diabetes. Algorithm]. 14 lpp. https://www.spkc.gov.lv/sites/spkc/files/data_content/4.cd_algoritms1.pdf (accessed 18.03.2021) (in Latvian).
- Dzīvīte-Krišāne, I., Konrāde, I., Lase, I., Lejnieks, A. (2013). Reto endokrīno slimību un ar tām saistīto elektrolītu traucējumu diagnostiskie algoritmi [Diagnostic algorithms for rare endocrine diseases and related electrolyte disorders]. https://whitemedicine.com/files/books/mini_RETO_G_v7_FINAL.pdf (accessed 10.02.2021) (in Latvian).
- Gulbis, E., Bandere, B., Gavars, D., Krišāne, A., Piekusa, T., Jupatova, D., Šelkova, S., Kaimiņa, L., Skaldere, R., Petersone, S., Plūme, I., Medvedeva, M., Balode, S., Grīviņa, I., Ivuškāne, S., Perminovs, D., Gavars, D. (2018). Klīnisko analīžu rokasgrāmata. [Handbook of Clinical Analyses]. E. Gulbja laboratorija. 608 lpp. (in Latvian).
- Hanas, R. (2019). Type 1 Diabetes in Children, Adolescents and Young Adults. Class Publishing. 464 pp. (at pp. 391, 410–417).
- Krzewska, A., Ben-Skowronek, I. (2016). Effect of associated autoimmune diseases on Type 1 Diabetes Mellitus incidence and metabolic control in children and adolescents. Biomed. Res. Int., 2016, 6219730. DOI: 10.1155/2016/6219730. https://pubmed.ncbi.nlm.nih.gov/27525273/.
- Levitsky, L. L., Madhusmita, M. (2020) Epidemiology, presentation, and diagnosis of type 1 diabetes mellitus in children and adolescents. https://www.uptodate.com/contents/epidemiology-presentation-and-diagnosis-of-type-1-diabetes-mellitus-in-children-and-adolescents# (acessed 30.03.2021).
- Mahmud, F. H., Elbarbary, N. S., Fröhlich-Reiterer, E., Holl, R. W., Kordonouri, O., Knip, M., Simmons, K., Craig, M. E. (2018). Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr. Diabetes, 19 (suppl. 27), 275–286. https://www.ispad.org/page/ISPADGuidelines2018. DOI: 10.1111/pedi.12740.
- Mayer-Davis, E. J., Kahkoska, A. R., Jefferies, C., Dabelea, D., Balde, N., Gong, C. X., Aschner, P., Craig, M. E. (2018). ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr. Diabetes, 19 (suppl. 27), 7–19. https://www.ispad.org/page/ISPADGuidelines2018. DOI: 10.1111/pedi.12773.
- Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., Pihoker, C., Saydah, S., Wagenknecht, L. (2017). SEARCH for diabetes in youth study. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. New Engl. J. Med., 376 (15), 1419–1429. DOI: 10.1056/NEJMoa1610187. PMID: 28402773; PMCID: PMC5592722. https://pubmed.ncbi.nlm.nih.gov/28402773/.
- DiMeglio, L. A., Acerini, C. L., Codner, E., Craig, M. E., Hofer, S. E., Pillay, K., Maahs, D. M. (2018). Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr. Diabetes, 19 (suppl. 27), 105–114. DOI: 10.1111/pedi.12737 (accessed 30.03.2021).
- Nawale, A., Suji, M. (2020). Quality of Life in children with Type 1 Diabetic – A systematic review. Indian J. Forensic Med. Tox., 14 (4), 4011. https://www.researchgate.net/publication/349109053_Quality_of_Life_in_Children_with_Type_1_Diabetic_-_A_Systematic_Review.
- Özyazıcıoğlu, N., Avdal, E. Ü., Sağlam, H. (2017). A determination of the quality of life of children and adolescents with type 1 diabetes and their parents. Int. J. Nurs. Sci., 4 (2), 94–98. DOI: 10.1016/j.ijnss.2017.01.008. PMID: 31406726; PMCID: PMC6626105. https://pubmed.ncbi.nlm.nih.gov/31406726/.
- Pham-Short, A., Donaghue, K. C., Amber, G., Garnett, S., Craig, M. E. (2016). Quality of life in Type 1 Diabetes and celiac disease: Role of the gluten-free diet. J. Pediatr., 179, 131–138. DOI: 10.1016/j.jpeds.2016.08.105. https://pubmed.ncbi.nlm.nih.gov/27720243/.
- Phelan, H., Lange, K., Cengiz, E., Gallego, P., Majaliwa, E., Pelicand, J., Smart, C., Hofer, S. E. (2018). ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents. Pediatr. Diabetes, 19 (suppl. 27), 75–83. https://www.ispad.org/page/ISPADGuidelines2018 DOI: 10.1111/pedi.12762.
- Šķestere, I. (2012). Pētījums par dzīves kvalitātes izvērtējuma metodēm un instrumentiem (1. daļa) [Research on quality of life assessment methods and tools (Part 1)] https://www.sif.gov.lv/nodevumi/nodevumi/4881/petijums_dz_kvalit_1.pdf (accessed 10.08.2020) (in Latvian).
- Varni, J. W. (1998). Pediatric Quality of Life Inventory Generic Core Scale. https://eprovide.mapi-trust.org/instruments/pediatric-quality-of-life-inventory (accessed 27.10.2020).
- Varni, J. W., Delamater, A. M., Hood, K. K., Raymond, J. K., Chang, N. T., Driscoll, K. A., Wong, J. C., Yi-Frazier, J. P., Grishman, E. K., Faith, M. A., Corathers, S. D., Kichler, J. C., Miller, J. L., Doskey, E. M., Heffer, R. W., Wilson, D. P. (2018). Pediatric Quality of Life Inventory 3.2 Diabetes Module Testing Study Consortium. PedsQL 3.2 Diabetes module for children, adolescents, and young adults: reliability and validity in type 1 diabetes. Diabetes Care, 41 (10), 2064–2071. DOI: 10.2337/dc17-2707. PMID: 30061317; PMCID: PMC6905504. https://pubmed.ncbi.nlm.nih.gov/30061317/.
- Varni, J. W., Seid, M., Rode, C. A. (1999). The PedsQL: measurement model for the pediatric quality of life inventory. Med. Care, 37 (2), 126–139. https://pubmed.ncbi.nlm.nih.gov/10024117/.
- Witek, P. R., Witek, J., Pańkowska, E. Choroby (2012). [Type 1 diabetes-associated autoimmune diseases: screening, diagnostic principles and management]. Med. Wieku Rozwoj, 16 (1), 23–34 (in Polish). PMID: 22516771. https://pubmed.ncbi.nlm.nih.gov/22516771/#:~:text=Type%201%20diabetes%20(T1D%20M)%20is,prevalent%20endocrinopathy%20among%20diabetic%20patients.
- Ziegler, R., Neu, A. (2018). Diabetes in childhood and adolescence. Dtsch Arztebl Int., 115 (9), 146–156. DOI: 10.3238/arztebl.2018.0146. PMID: 29563012; PMCID: PMC5876549. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876549/.